Terumo Revenue 2012-2021 | TRUMY

Terumo annual/quarterly revenue history and growth rate from 2012 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Terumo revenue for the quarter ending June 30, 2021 was $1.563B, a 18.76% increase year-over-year.
  • Terumo revenue for the twelve months ending June 30, 2021 was $4.172B, a 12.77% decline year-over-year.
  • Terumo annual revenue for 2021 was $5.77B, a 0.27% decline from 2020.
  • Terumo annual revenue for 2020 was $5.786B, a 7.24% increase from 2019.
  • Terumo annual revenue for 2019 was $5.395B, a 1.99% increase from 2018.
Terumo Annual Revenue
(Millions of US $)
2021 $5,770
2020 $5,786
2019 $5,395
2018 $5,290
2017 $4,782
2016 $4,358
2015 $4,476
2014 $4,674
2013 $4,868
2012 $4,911
Terumo Quarterly Revenue
(Millions of US $)
2021-06-30 $1,563
2020-12-31
2020-06-30 $1,221
2019-06-30 $1,388
2018-06-30 $1,316
2017-06-30 $1,254
2016-06-30 $1,158
2015-06-30 $1,055
2015-03-31 $1,061
2014-12-31 $1,143
2014-09-30 $1,136
2014-06-30 $1,123
2014-03-31 $1,221
2013-12-31 $1,192
2013-09-30 $1,161
2013-06-30 $1,122
2013-03-31 $1,289
2012-12-31 $1,278
2012-09-30 $1,219
2012-06-30 $1,198
2012-03-31 $1,242
2011-12-31 $1,267
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.317B $5.790B
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $197.401B 20.06
Medtronic (MDT) Ireland $138.943B 18.50
Stryker (SYK) United States $87.811B 25.43
Boston Scientific (BSX) United States $57.512B 24.38
Baxter (BAX) United States $36.314B 19.03
ResMed (RMD) United States $28.000B 33.88
Zimmer Biomet Holdings (ZBH) United States $24.405B 16.02
Koninklijke Philips (PHG) Netherlands $22.333B 15.32
Bio-Rad Laboratories (BIO) United States $15.075B 32.69
Smith & Nephew SNATS (SNN) United Kingdom $13.719B 0.00
Envista Holdings (NVST) United States $6.721B 21.64
Perrigo (PRGO) Ireland $5.048B 19.96
BellRing Brands (BRBR) United States $3.393B 24.16
Haemonetics (HAE) United States $3.018B 22.80
Owens & Minor (OMI) United States $2.671B 9.83
Warby Parker (WRBY) United States $1.564B 0.00
Zevia PBC (ZVIA) United States $0.140B 0.00
Vapotherm (VAPO) United States $0.084B 0.00